Author name: Prashant Reddy

T. Prashant Reddy graduated from the National Law School of India University, Bangalore, with a B.A.LLB (Hons.) degree in 2008. He later graduated with a LLM degree (Law, Science & Technology) from the Stanford Law School in 2013. Prashant has worked with law firms in Delhi and in academia in India and Singapore. He is also co-author of the book Create, Copy, Disrupt: India's Intellectual Property Dilemmas (OUP).

USV wins appeal against USPTO decision.

The latest as reported by PharmaBiz.com and Business Line is that USV Ltd. an Indian Pharma company has won against an appeal against an Order of the USPTO over a drug salt donepezil oxalate. The appeal against the USPTO Order lay with the Board of Patent Appeals and Interferences which rendered its decision on Feb 5th, 2008. The decision is available on the website of the Board. The appeal was Appeal No. 2007-4478. At the examination stage the examiner had […]

USV wins appeal against USPTO decision. Read More »

What’s the solution to YouTube’s infringing tactics?

Very recently Sumathi had informed us that the Utube-Tseries litigation may end because the parties seem to be headed for an out of court settlement. SpicyIP however was curious about how other countries are dealing with the growing complaints of copyright infringement against online content providers and decided to research a little on it. We dug up some mildly interesting material.Apparently late in 2007 Google Video had been held liable for copyright infringement of a documentary called ‘Tranquillity Bay’ by

What’s the solution to YouTube’s infringing tactics? Read More »

SpicyIP Petition to bear fruit by early 2009

As most of you will recollect SpicyIP has been lamenting for some time now about the lack of a digitised database on patents granted by the Indian Patent Office. In an inspired bid to give vent to our collective frustrations on this matter Shamnad came up with the idea of sending a SpicyIP I-Petition to the Government of India in regards this sorry state of affairs. The SpicyIP I-Petition was a huge success because so many of you signed up,

SpicyIP Petition to bear fruit by early 2009 Read More »

Chinese pharma poses serious competition to Indian Pharma: PharmaBiz

PharmaBiz.com reports that Chinese pharmaceutical companies are posing a serious threat to their Indian counterparts. As usual the Chinese who are past-masters at reverse engineering have started manufacturing drugs at prices cheaper than Indian drugs. Active pharmaceutical ingredient (API) units in India have already faced severe competition in the country during the last ten years leading to several units shutting down but the threat now is to the formulations industry. The Indian pharmaceutical industry is lobbying hard to ensure that

Chinese pharma poses serious competition to Indian Pharma: PharmaBiz Read More »

The .Asia domain launched under a ‘sunrise policy’

The DotAsia Organization, an umbrella organization of various national top-level domain registries around Asia (including .IN in India), has launched the global “.Asia” Internet domain for the Asia region under a sunrise policy which gives a preference to trademark owners and celebrities. (Press release available here) Most domain name launches are a nightmare for trademark owners and celebrities since it means protecting their trademark and identity in yet another jurisdiction. More troubling for them however is the fact that most

The .Asia domain launched under a ‘sunrise policy’ Read More »

SpicyIP Tidbit: Natco’s ‘compulsory licensing’ request to come up for hearing next week

IP Watch reports that Natco’s request for a compulsory license to export anti-cancer drugs to Nepal, is going to come up for hearing by the end of February. (Full story is available here) As most of our readers must know SpicyIP had covered this case extensively a couple of weeks ago. The request for compulsory licensing was made under S. 92A of the Patent Act, which allows for ‘compulsory licensing for export of patented pharmaceutical products in certain exceptional circumstances’.

SpicyIP Tidbit: Natco’s ‘compulsory licensing’ request to come up for hearing next week Read More »

SpicyIP Events: NLSIU to hold a National Symposium on Challenges to India’s Patent Regime on the 12th and 13th of April

The National Law School of India University (NLSIU), Bangalore is going to hold a National Symposium on Challenges to India’s Patent Regime on the 12th and 13th of April, 2008. The symposium is being organized by the Editorial Board of the National Law School of India Review (NLSIR) – NLS’s flagship journal formerly known as the Student Bar Review. The website can be accessed here. The concept note for the Symposium is available here. As per the website of the

SpicyIP Events: NLSIU to hold a National Symposium on Challenges to India’s Patent Regime on the 12th and 13th of April Read More »

A spicy GI

SpicyIP has always had a natural tendency to report on the ‘spicier’ issues of IP law. So just imagine our excitement when we found out about Geographical Indication protection for spices. We however promise to refrain from over-using the ‘spicy’ puns that come to our minds. The latest is Assam’s ‘Karbi Anglong ginger’ which is well on track to receive GI protection. The district administration recently filed an application claiming GI protection for GIs. The Karbi Anglong ginger is supposed

A spicy GI Read More »

Mr. Augustine and his patented ‘tender coconut wine’

‘God’s own country’ – Kerala gives us yet another product to relax and soothe those frayed nerves of yours. ‘Tender coconut wine’ made from ‘tender coconut water’ was granted patent (No. 209015) on Aug 16 last year by the Indian Patent Office. (My many thanks to Shamnad our man from Mallu land for directing me to this story.) The patent is in the name of Sebastian P. Augustine a farmer, from Kalsgrod Districtin Kerala, who has won the won the

Mr. Augustine and his patented ‘tender coconut wine’ Read More »

Is the Indian drug industry scared of the NPPA?

For all you bleeding hearts out there pining away about pharma companies over-charging on all their drugs here’s some good news. The National Pharmaceutical Pricing Authority (NPPA) has become rather active over the last few months – so much so that the drug industry was seriously contemplating moving the judiciary to seek a reprieve. UPDATE: They actually did move the Delhi High Court for some relief and the Court actually asked the Ministry of Chemicals and Fertilizers to look into

Is the Indian drug industry scared of the NPPA? Read More »

Scroll to Top